SE8003243L - 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa - Google Patents

5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa

Info

Publication number
SE8003243L
SE8003243L SE8003243A SE8003243A SE8003243L SE 8003243 L SE8003243 L SE 8003243L SE 8003243 A SE8003243 A SE 8003243A SE 8003243 A SE8003243 A SE 8003243A SE 8003243 L SE8003243 L SE 8003243L
Authority
SE
Sweden
Prior art keywords
benzodioxan
ylmethyl
dihydro
hydroxyethyl
amino
Prior art date
Application number
SE8003243A
Other languages
English (en)
Other versions
SE434745B (sv
Inventor
J M Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE8003243L publication Critical patent/SE8003243L/sv
Publication of SE434745B publication Critical patent/SE434745B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SE8003243A 1979-05-04 1980-04-29 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa SE434745B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives

Publications (2)

Publication Number Publication Date
SE8003243L true SE8003243L (sv) 1980-11-05
SE434745B SE434745B (sv) 1984-08-13

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003243A SE434745B (sv) 1979-05-04 1980-04-29 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa

Country Status (21)

Country Link
US (1) US4206125A (sv)
JP (1) JPS55147274A (sv)
AT (1) AT369365B (sv)
AU (1) AU531739B2 (sv)
BE (1) BE883087A (sv)
CA (1) CA1148963A (sv)
CH (1) CH645372A5 (sv)
DE (1) DE3014738A1 (sv)
DK (1) DK154503C (sv)
ES (1) ES8104997A1 (sv)
FR (1) FR2455598A1 (sv)
GB (1) GB2051780B (sv)
IE (1) IE49564B1 (sv)
IL (1) IL59681A (sv)
IT (1) IT1127441B (sv)
NL (1) NL8002208A (sv)
NO (1) NO153572C (sv)
NZ (1) NZ193236A (sv)
PH (1) PH15963A (sv)
SE (1) SE434745B (sv)
ZA (1) ZA801603B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
ES2291733T3 (es) * 2002-10-22 2008-03-01 Glaxo Group Limited Compuestos de ariletanolamina medicinales.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054104A (sv) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Also Published As

Publication number Publication date
IL59681A0 (en) 1980-06-30
CA1148963A (en) 1983-06-28
NO801296L (no) 1980-11-05
CH645372A5 (de) 1984-09-28
AT369365B (de) 1982-12-27
AU531739B2 (en) 1983-09-01
IT8048373A0 (it) 1980-04-09
IE49564B1 (en) 1985-10-30
ES490814A0 (es) 1981-05-16
IE800572L (en) 1980-11-04
FR2455598B1 (sv) 1983-05-27
DE3014738A1 (de) 1980-11-13
AU5707780A (en) 1980-11-06
ZA801603B (en) 1981-03-25
GB2051780A (en) 1981-01-21
DK154503C (da) 1989-04-10
JPS642115B2 (sv) 1989-01-13
FR2455598A1 (fr) 1980-11-28
NZ193236A (en) 1982-09-14
NO153572C (no) 1986-04-16
GB2051780B (en) 1982-12-22
DE3014738C2 (sv) 1989-08-03
NL8002208A (nl) 1980-11-06
ATA232780A (de) 1982-05-15
BE883087A (fr) 1980-09-01
DK193580A (da) 1980-11-05
DK154503B (da) 1988-11-21
PH15963A (en) 1983-05-04
IT1127441B (it) 1986-05-21
SE434745B (sv) 1984-08-13
ES8104997A1 (es) 1981-05-16
IL59681A (en) 1984-04-30
NO153572B (no) 1986-01-06
US4206125A (en) 1980-06-03
JPS55147274A (en) 1980-11-17

Similar Documents

Publication Publication Date Title
PT97602A (pt) Processo para a preparacao de indolonas neuroprotectoras e de derivados relacionados com as mesmas
ES516561A0 (es) Procedimiento para la obtencion de acidos 1-carboxi-(alcanoil o aralcanoil)-indolin-2-carboxilicos.
SE8302693L (sv) Heterocykliska foreningar
PT89814A (pt) Processo para a preparacao de novos derivados do estilbeno e de composicoes farmaceuticas que os contem
BR9712507A (pt) Derivados de aminotiazol, seu processo de preparo e as composições famacêuticas que os comtêm.
SE7603085L (sv) Diazepinderivat
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES503678A0 (es) Procedimiento para la preparacion de derivados de imidazol
SE8003243L (sv) 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa
FI802023A (fi) 1-alkadien-2,4-yl-2-hydroxylmetyl-3,4,5-trihydroxipiperidiner foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE7705310L (sv) Kinazolinderivat
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
FI900646A0 (fi) Foerfarande foer framstaellning av fenylhydrazoner och ur dessa erhaollna laekemedel och kosmetiska aemnen.
SE8003244L (sv) 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa
ES497693A0 (es) Procedimiento para la obtencion de derivados de benzotiazol
FI852743A0 (fi) Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni.
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
FI833119A (fi) Substituerade bensensulfonylsyraestrar, foerfaranden foer deras framstaellning och anvaendning daersom laekemedel
SE8503225D0 (sv) Diacyloxi-1,8-acyl-10-antroner, sett for deras framstellning och deras anvendning som lekemedel for djur och menniska samt for kosmetika
ES511968A0 (es) Procedimiento para la obtencion de sulfamidas anulares.
ES538155A0 (es) Procedimiento para la obtencion de un derivado de arganofosfato
SE7910612L (sv) Metod att kontrollera hypertension och intestinala sjukdomar samt kompositioner
DE69129238D1 (de) Okulare hypotensive homo-prostaglandinderivate
ES497737A0 (es) Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina
ES523235A0 (es) "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina"

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8003243-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8003243-6

Format of ref document f/p: F